The Patent 1000 focuses exclusively on patent practice and has firmly established itself as the definitive 'go-to' resource for those seeking world-class legal patent expertise.
Bronze - Firms: litigation
Haug Partners may have made its name as an agile, business-focused contentious force, but today it is increasingly seen as a well-rounded boutique with a deft counselling touch and cultivated prosecution and transactions capabilities. The main headlines are still written by the group’s redoubtable trial lawyers, who include Edgar Haug, Porter Fleming and Brian Slater. Haug is distinguished by his first-chair seasoning, appellate expertise and international experience; Fleming by his tirelessness and tenacity; and Slater by his life sciences industry knowledge and versatile patent procurement, licensing and enforcement skillset.
Positioning itself for the future, as it has done throughout the course of its existence, Haug Partners LLP continues to evolve, meeting the needs of its clients and the challenges facing the legal community. Though much has changed since we opened our doors in 1997, our commitment to excellence, innovation and integrity in servicing our clients’ needs has not wavered. Originally established in New York City on the traditional IP practices of patent prosecution and litigation, the firm has grown and redefined its practice areas so that it now encompasses various areas of law to complement its founding areas of expertise. Our geographic expansion into Washington DC and Boston reflects that growth into a full-service IP practice.
The mission of Haug Partners over its 20+-year history has been to provide synthesised, multidisciplinary legal services for life sciences and technology businesses. Our size, structure and technical capabilities enable us to seamlessly assimilate our various specialties, thus efficiently assisting our clients in the creation, expansion and protection of their intellectual property. We align product, patent, regulatory and commercial life cycle strategies with the timelines, business goals and resources of those we represent. Our personalised guidance has been a hallmark of how we address our clients’ objectives.
Haug Partners delivers added value by assembling a multidisciplinary team tailored to each client’s needs that thoroughly analyses a matter, develops a comprehensive legal strategy and then delivers an integrated solution. We continue to be second to none in the areas of IP preparation, procurement and litigation. The firm’s flagship New York City office boasts a state-of-the-art litigation suite with a fully functional mock courtroom. Our expanded and redefined service offerings include Food and Drug Administration compliance; antitrust litigation and counselling; due diligence; International Trade Commission actions; commercial investigations, compliance, risk mitigation and litigation; licensing and transactions; and trademarks and unfair competition.
Haug Partners’ strength resides in its people. We have attorneys and advisers with advanced degrees in specialised technical fields and extensive industry experience. Our team includes former research scientists, in-house corporate counsel, government attorneys, US Patent and Trademark Office examiners and US Patent and Trial Appeal Board judges. Our core practice area since our inception has been the life sciences, where we have represented clients in the pharmaceutical, chemical, biotechnology, medical device and cosmetic space. Through our expansion, we now work across a broad range of industries, including in the aerospace, automotive, information technology, e-commerce, consumer electronics, telecommunications, energy, semiconductors, financial services and insurance sectors. We assist clients from the inception of an idea through commercialisation and next-generation planning. Our technical expertise, legal acumen and business judgement enables us to consistently deliver optimal outcomes.
Haug Partners values contribution to the legal community through service in bar and industry associations, including the Federal Circuit Bar Association, the Licensing Executives Society, ChIPs, the International Trademark Association, the Intellectual Property Organization, the Patent Trial and Appeal Board, Biotechnology Innovation Organisation (BIO) International, NJ BIO, MassBIO and the Food and Drug Law Institute. Our frontline involvement in these organisations enables us to influence law and policy to the benefit of our profession. We also participate in numerous pro bono organisations, including Volunteer Lawyers for the Arts, New York Lawyers for the Public Interest, the Innocence Project, the Veterans Consortium Pro Bono Program, New Jersey Patent Rules Committee and the New York City Corporation Counsel. The firm has assisted pro bono clients in matters that include administrative proceedings before the federal government and at all levels of the court system, including before the US Supreme Court.
Haug Partners is conscious of the dynamic environment of intellectual property, whether stemming from precedential court decisions, developing agency guidelines or game-changing bills passed by Congress. However, we recognise that the marketplace and the factors that influence our clients’ assets are global. To protect these assets worldwide, Haug Partners has developed and maintains close working partnerships with law firms in Germany, the United Kingdom, China and Japan. We collaborate with all of our clients to provide comprehensive legal strategies consistent with the global, ever-changing legal, regulatory and commercial environment in which they operate.